None
Conditions
Interventions
Exposure Group:None
Non-exposed group:None
Sponsors
Sichuan Orthopaedic Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Age >= 18 years and <= 80 years, with no gender restriction; 2.Confirmed by clinical, imaging and pathological examinations, meeting the indications for hip arthroplasty, and undergoing the procedure successfully; 3. Received one of the two analgesia regimens specified in this study postoperatively (fascia iliaca compartment block + patient-controlled intravenous analgesia or fascia iliaca compartment block + patient-controlled continuous nerve block analgesia), with no changes to the analgesic protocol throughout the treatment period; 4.Complete clinical data (including preoperative baseline data, surgery-related information, postoperative analgesia records, adverse reaction records, muscle strength assessment records, follow-up data, etc.); 5. Followed up postoperatively until discharge with complete follow-up data and no significant loss to follow-up.
Exclusion criteria
Exclusion criteria: 1.Patients with severe dysfunction of vital organs including heart, liver, kidney and lung, or with coagulation disorders or immune system diseases; 2.Patients with hypersensitivity to drugs used in the two analgesia regimens (local anesthetics, opioids, etc.); 3.Patients with preoperative hip muscle strength abnormalities or neurological diseases (such as Parkinson’s disease, hemiplegia, etc.) that may affect postoperative muscle strength assessment; 4.Patients who developed severe postoperative complications (such as prosthesis dislocation, infection, massive hemorrhage, etc.) affecting the evaluation of analgesic effect and muscle strength recovery; 5. Patients with severe missing clinical data (missing >=30% of key indicators such as VAS score, muscle strength grade, adverse reaction records) or loss to follow-up; 6. Patients with mental illness or cognitive dysfunction who are unable to cooperate with pain assessment and muscle strength examination.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postoperative Visual Analogue Scale Score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Postoperative adverse events;Muscle strength recovery condition; | — |
Countries
China
Contacts
Public ContactLi Man
Sichuan Orthopaedic Hospital
Outcome results
None listed